Chemicals - Specialty
Compare Stocks
5 / 10Stock Comparison
HWKN vs TROX vs CC vs IOSP vs ALB
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals
Chemicals - Specialty
Chemicals - Specialty
Chemicals - Specialty
HWKN vs TROX vs CC vs IOSP vs ALB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $3.47B | $1.41B | $3.46B | $2.00B | $24.00B |
| Revenue (TTM) | $1.06B | $2.92B | $5.82B | $1.79B | $5.49B |
| Net Income (TTM) | $82M | $-359M | $-411M | $114M | $-233M |
| Gross Margin | 22.9% | 5.8% | 15.1% | 27.4% | 18.5% |
| Operating Margin | 11.5% | -4.8% | -0.8% | 8.3% | 5.6% |
| Forward P/E | 42.4x | — | 15.9x | 16.2x | 19.4x |
| Total Debt | $160M | $3.59B | $4.58B | $90M | $3.30B |
| Cash & Equiv. | $5M | $211M | $672M | $293M | $1.62B |
HWKN vs TROX vs CC vs IOSP vs ALB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Hawkins, Inc. (HWKN) | 100 | 779.3 | +679.3% |
| Tronox Holdings plc (TROX) | 100 | 132.8 | +32.8% |
| The Chemours Company (CC) | 100 | 175.7 | +75.7% |
| Innospec Inc. (IOSP) | 100 | 104.5 | +4.5% |
| Albemarle Corporati… (ALB) | 100 | 266.0 | +166.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HWKN vs TROX vs CC vs IOSP vs ALB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HWKN carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 6.0%, EPS growth 12.3%, 3Y rev CAGR 8.0%
- 7.7% 10Y total return vs ALB's 224.7%
- 6.0% revenue growth vs TROX's -5.7%
- 7.8% margin vs TROX's -12.3%
TROX ranks third and is worth considering specifically for dividends.
- 3.4% yield, vs ALB's 0.8%
Among these 5 stocks, CC doesn't own a clear edge in any measured category.
IOSP is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 12 yrs, beta 0.71, yield 2.1%
- Lower volatility, beta 0.71, Low D/E 6.7%, current ratio 2.79x
- PEG 0.51 vs HWKN's 1.71
- Beta 0.71, yield 2.1%, current ratio 2.79x
ALB is the clearest fit if your priority is momentum.
- +257.1% vs IOSP's -11.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.0% revenue growth vs TROX's -5.7% | |
| Value | Lower P/E (16.2x vs 19.4x) | |
| Quality / Margins | 7.8% margin vs TROX's -12.3% | |
| Stability / Safety | Beta 0.71 vs TROX's 2.38, lower leverage | |
| Dividends | 3.4% yield, vs ALB's 0.8% | |
| Momentum (1Y) | +257.1% vs IOSP's -11.9% | |
| Efficiency (ROA) | 8.4% ROA vs TROX's -7.7%, ROIC 15.9% vs -0.3% |
HWKN vs TROX vs CC vs IOSP vs ALB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HWKN vs TROX vs CC vs IOSP vs ALB — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HWKN leads in 2 of 6 categories
IOSP leads 1 • TROX leads 0 • CC leads 0 • ALB leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — HWKN and ALB each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CC is the larger business by revenue, generating $5.8B annually — 5.5x HWKN's $1.1B. HWKN is the more profitable business, keeping 7.8% of every revenue dollar as net income compared to TROX's -12.3%. On growth, ALB holds the edge at +32.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.1B | $2.9B | $5.8B | $1.8B | $5.5B |
| EBITDAEarnings before interest/tax | $172M | $166M | -$132M | $181M | $802M |
| Net IncomeAfter-tax profit | $82M | -$359M | -$411M | $114M | -$233M |
| Free Cash FlowCash after capex | $88M | -$275M | $198M | $77M | $577M |
| Gross MarginGross profit ÷ Revenue | +22.9% | +5.8% | +15.1% | +27.4% | +18.5% |
| Operating MarginEBIT ÷ Revenue | +11.5% | -4.8% | -0.8% | +8.3% | +5.6% |
| Net MarginNet income ÷ Revenue | +7.8% | -12.3% | -7.1% | +6.4% | -4.2% |
| FCF MarginFCF ÷ Revenue | +8.2% | -9.4% | +3.4% | +4.3% | +10.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.9% | +3.0% | +1.0% | +2.8% | +32.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -4.2% | +7.1% | -6.1% | -6.9% | — |
Valuation Metrics
IOSP leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 17.2x trailing earnings, IOSP trades at a 58% valuation discount to HWKN's 41.5x P/E. Adjusting for growth (PEG ratio), IOSP offers better value at 0.54x vs HWKN's 1.67x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.5B | $1.4B | $3.5B | $2.0B | $24.0B |
| Enterprise ValueMkt cap + debt − cash | $3.6B | $4.8B | $7.4B | $1.8B | $25.7B |
| Trailing P/EPrice ÷ TTM EPS | 41.48x | -2.97x | -9.00x | 17.25x | -35.39x |
| Forward P/EPrice ÷ next-FY EPS est. | 42.35x | — | 15.86x | 16.24x | 19.37x |
| PEG RatioP/E ÷ EPS growth rate | 1.67x | — | — | 0.54x | — |
| EV / EBITDAEnterprise value multiple | 22.76x | 17.03x | 22.00x | 8.76x | 34.04x |
| Price / SalesMarket cap ÷ Revenue | 3.56x | 0.49x | 0.60x | 1.13x | 4.67x |
| Price / BookPrice ÷ Book value/share | 7.60x | 0.96x | 13.82x | 1.51x | 2.45x |
| Price / FCFMarket cap ÷ FCF | 49.53x | — | 67.80x | 22.78x | 34.66x |
Profitability & Efficiency
HWKN leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
HWKN delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-163 for CC. IOSP carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to CC's 18.27x. On the Piotroski fundamental quality scale (0–9), HWKN scores 6/9 vs TROX's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +15.9% | -30.4% | -163.4% | +8.5% | -2.3% |
| ROA (TTM)Return on assets | +8.4% | -7.7% | -5.5% | +6.3% | -1.4% |
| ROICReturn on invested capital | +15.9% | -0.3% | -0.1% | +11.2% | +0.6% |
| ROCEReturn on capital employed | +19.3% | -0.4% | -0.1% | +11.0% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 2 | 4 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.35x | 2.48x | 18.27x | 0.07x | 0.34x |
| Net DebtTotal debt minus cash | $155M | $3.4B | $3.9B | -$203M | $1.7B |
| Cash & Equiv.Liquid assets | $5M | $211M | $672M | $293M | $1.6B |
| Total DebtShort + long-term debt | $160M | $3.6B | $4.6B | $90M | $3.3B |
| Interest CoverageEBIT ÷ Interest expense | 10.27x | -1.16x | 1.15x | — | 1.59x |
Total Returns (Dividends Reinvested)
HWKN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HWKN five years ago would be worth $50,906 today (with dividends reinvested), compared to $4,719 for TROX. Over the past 12 months, ALB leads with a +257.1% total return vs IOSP's -11.9%. The 3-year compound annual growth rate (CAGR) favors HWKN at 61.2% vs TROX's -7.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +15.2% | +107.7% | +88.8% | +5.6% | +41.7% |
| 1-Year ReturnPast 12 months | +40.6% | +77.6% | +108.1% | -11.9% | +257.1% |
| 3-Year ReturnCumulative with dividends | +319.2% | -20.4% | -13.5% | -13.4% | +12.1% |
| 5-Year ReturnCumulative with dividends | +409.1% | -52.8% | -19.8% | -12.7% | +32.6% |
| 10-Year ReturnCumulative with dividends | +766.7% | +123.7% | +226.5% | +92.6% | +224.7% |
| CAGR (3Y)Annualised 3-year return | +61.2% | -7.3% | -4.7% | -4.7% | +3.9% |
Risk & Volatility
Evenly matched — IOSP and ALB each lead in 1 of 2 comparable metrics.
Risk & Volatility
IOSP is the less volatile stock with a 0.71 beta — it tends to amplify market swings less than TROX's 2.38 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALB currently trades 92.1% from its 52-week high vs CC's 80.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.94x | 2.38x | 1.81x | 0.71x | 1.57x |
| 52-Week HighHighest price in past year | $186.15 | $10.59 | $28.67 | $95.55 | $221.00 |
| 52-Week LowLowest price in past year | $115.35 | $2.86 | $9.13 | $65.58 | $53.70 |
| % of 52W HighCurrent price vs 52-week peak | +89.8% | +83.3% | +80.4% | +84.3% | +92.1% |
| RSI (14)Momentum oscillator 0–100 | 62.7 | 40.6 | 43.2 | 53.9 | 56.4 |
| Avg Volume (50D)Average daily shares traded | 168K | 3.1M | 3.1M | 224K | 2.0M |
Analyst Outlook
Evenly matched — TROX and ALB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HWKN as "Buy", TROX as "Buy", CC as "Hold", IOSP as "Hold", ALB as "Hold". Consensus price targets imply 42.8% upside for IOSP (target: $115) vs -15.0% for TROX (target: $8). For income investors, TROX offers the higher dividend yield at 3.43% vs HWKN's 0.42%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | — | $7.50 | $24.14 | $115.00 | $196.40 |
| # AnalystsCovering analysts | 1 | 17 | 20 | 9 | 45 |
| Dividend YieldAnnual dividend ÷ price | +0.4% | +3.4% | +2.2% | +2.1% | +0.8% |
| Dividend StreakConsecutive years of raises | 5 | 0 | 0 | 12 | 15 |
| Dividend / ShareAnnual DPS | $0.70 | $0.30 | $0.52 | $1.70 | $1.62 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.7% | 0.0% | 0.0% | 0.0% | 0.0% |
HWKN leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). IOSP leads in 1 (Valuation Metrics). 3 tied.
HWKN vs TROX vs CC vs IOSP vs ALB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HWKN or TROX or CC or IOSP or ALB a better buy right now?
For growth investors, Hawkins, Inc.
(HWKN) is the stronger pick with 6. 0% revenue growth year-over-year, versus -5. 7% for Tronox Holdings plc (TROX). Innospec Inc. (IOSP) offers the better valuation at 17. 2x trailing P/E (16. 2x forward), making it the more compelling value choice. Analysts rate Hawkins, Inc. (HWKN) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HWKN or TROX or CC or IOSP or ALB?
On trailing P/E, Innospec Inc.
(IOSP) is the cheapest at 17. 2x versus Hawkins, Inc. at 41. 5x. On forward P/E, The Chemours Company is actually cheaper at 15. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Innospec Inc. wins at 0. 51x versus Hawkins, Inc. 's 1. 71x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — HWKN or TROX or CC or IOSP or ALB?
Over the past 5 years, Hawkins, Inc.
(HWKN) delivered a total return of +409. 1%, compared to -52. 8% for Tronox Holdings plc (TROX). Over 10 years, the gap is even starker: HWKN returned +766. 7% versus IOSP's +92. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HWKN or TROX or CC or IOSP or ALB?
By beta (market sensitivity over 5 years), Innospec Inc.
(IOSP) is the lower-risk stock at 0. 71β versus Tronox Holdings plc's 2. 38β — meaning TROX is approximately 235% more volatile than IOSP relative to the S&P 500. On balance sheet safety, Innospec Inc. (IOSP) carries a lower debt/equity ratio of 7% versus 18% for The Chemours Company — giving it more financial flexibility in a downturn.
05Which is growing faster — HWKN or TROX or CC or IOSP or ALB?
By revenue growth (latest reported year), Hawkins, Inc.
(HWKN) is pulling ahead at 6. 0% versus -5. 7% for Tronox Holdings plc (TROX). On earnings-per-share growth, the picture is similar: Innospec Inc. grew EPS 228. 9% year-over-year, compared to -890. 0% for Tronox Holdings plc. Over a 3-year CAGR, HWKN leads at 8. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HWKN or TROX or CC or IOSP or ALB?
Hawkins, Inc.
(HWKN) is the more profitable company, earning 8. 7% net margin versus -16. 2% for Tronox Holdings plc — meaning it keeps 8. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HWKN leads at 12. 2% versus -0. 7% for TROX. At the gross margin level — before operating expenses — IOSP leads at 27. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HWKN or TROX or CC or IOSP or ALB more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Innospec Inc. (IOSP) is the more undervalued stock at a PEG of 0. 51x versus Hawkins, Inc. 's 1. 71x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, The Chemours Company (CC) trades at 15. 9x forward P/E versus 42. 4x for Hawkins, Inc. — 26. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IOSP: 42. 8% to $115. 00.
08Which pays a better dividend — HWKN or TROX or CC or IOSP or ALB?
All stocks in this comparison pay dividends.
Tronox Holdings plc (TROX) offers the highest yield at 3. 4%, versus 0. 4% for Hawkins, Inc. (HWKN).
09Is HWKN or TROX or CC or IOSP or ALB better for a retirement portfolio?
For long-horizon retirement investors, Innospec Inc.
(IOSP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 71), 2. 1% yield). Tronox Holdings plc (TROX) carries a higher beta of 2. 38 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IOSP: +92. 6%, TROX: +123. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HWKN and TROX and CC and IOSP and ALB?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: HWKN is a small-cap quality compounder stock; TROX is a small-cap income-oriented stock; CC is a small-cap quality compounder stock; IOSP is a small-cap deep-value stock; ALB is a mid-cap quality compounder stock. TROX, CC, IOSP, ALB pay a dividend while HWKN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.